Sign up to save your podcasts
Or
Share ADAPTABLE TRIAL. aspirin doses for secondary prevention. NEJM 2021.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ADAPTABLE TRIAL. aspirin doses for secondary prevention. NEJM 2021.
#ADAPTABLE trial was recently published in NEJM 2021 and it was also presented at ACC 2021 conference. It compared #HighDoseAspirin and #LowDoseAspirin in patients receiving it for secondary prevention.
Follow Cardio-Ed for more such content. We discuss Recent advances, recent guidelines and recent articles in cardiology as well as core concepts in Cardiology.
https://youtube.com/channel/UCVxInTblTpoy-THMuSxNyvw
View all episodes
By The Cardio Ed Podcast
5
11 ratings
#ADAPTABLE trial was recently published in NEJM 2021 and it was also presented at ACC 2021 conference. It compared #HighDoseAspirin and #LowDoseAspirin in patients receiving it for secondary prevention.
Follow Cardio-Ed for more such content. We discuss Recent advances, recent guidelines and recent articles in cardiology as well as core concepts in Cardiology.
https://youtube.com/channel/UCVxInTblTpoy-THMuSxNyvw